Congratulations to UM Programme Lead Professor Stewart who was awarded an NIHR CRN East of England Cancer Research Excellence Award in the category of Medical Research Excellence.
The award citation is reprinted in full below:
Professor Grant Stewart is a Professor of Surgical Oncology at the University of Cambridge, with a focus on developing and promoting surgery related clinical trials and translational research.
Grant brings unique leadership of systemic therapy based trials which has brought together teams of surgeons, oncologists, pathologists and radiologists across the UK and internationally. As CI of the positive NAXIVA trial he delivered it to publication and is now working to deliver its follow on study design. As CI of the WIRE trial he has driven the trial to remain on track, despite a CUHFT mandated stoppage for COVID, and the trial is being developed as a platform for future trials.
Professor Stewart has been instrumental in the SORCE and RAMPART adjuvant systemic therapy trials which are practice confirming and changing studies and as CI of the translational arm of RAMPART (TransRAMPART) has won essential funding to investigate underlying mechanisms of response, resistance and toxicity to immunotherapy.
Highly supportive of his colleagues and trainees, he has developed new PIs and CIs from non-traditional clinical trial backgrounds eg. several urologists (Steve Bromage, Chris Blick, Alex Laird) to run clinical trials and as co-lead of the CRUK Cambridge Centre Urological Malignancies Programme (UMP), he is a tireless supporter of trainees and young academic clinicians and basic scientists with all his PhD students and ACFs/ACL trainees continuing to pursue academic careers.
As Chair of the NCRI Renal Cancer Surgical Subgroup 2015-2020 he developed the portfolio of surgery-related clinical trials from 0 to 5 and in the process engaged a new cadre of surgical clinical trialists which continues to exist today.
During COVID, when surgery became more limited he helped to set up the RECOVERY clinical trial at Cambridge University Hospital with Dr Mark Toshner which has been a phenomenally successful practice changing trial.
Comentarios